Skip to main content
Top
Published in: International Urology and Nephrology 3/2007

01-09-2007 | Original Paper

Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal prostate biopsy

Authors: Athanasios N. Argyropoulos, Konstantinos Doumas, Antonios Farmakis, Ioannis Liakatas, Ioannis Gkialas, Michael Lykourinas

Published in: International Urology and Nephrology | Issue 3/2007

Login to get access

Abstract

Objective

To evaluate the efficacy of two prophylactic schemes for prostate biopsy using a single dose of oral levofloxacin given either before, or immediately after transrectal ultrasound-guided prostate biopsy.

Materials and methods

A total of 300 men formed two groups of 150 patients each: the first group received one dose of 500 mg of levofloxacin 30 min to an hour before, and the second group the same antibiotic immediately after prostate biopsy. No pre-biopsy enema was used. Side effects after prostate biopsy were recorded, and the two groups were compared.

Results

Only one patient from the first group developed a urinary tract infection after biopsy. A mean number of more than 10 cores per patient were taken. Haematuria was the most common complaint, followed by haemospermia. Haematuria and rectal bleeding were more common in patients where more than 8 cores were taken from the prostate (P = 0.005 and P = 0.017, respectively). Prostate cancer was detected in 34.3% of patients in total.

Conclusion

The use of a single dose of 500 mg levofloxacin given immediately after prostate biopsy proved to be quite effective for the prevention of infectious complications, even in the setting of an extensive biopsy protocol.
Literature
1.
go back to reference Schmid HP, Prikler L, Sturgeon CM et al (2003) Diagnosis of prostate cancer—the clinical use of prostate specific antigen. EAU Update Series 1:3–8CrossRef Schmid HP, Prikler L, Sturgeon CM et al (2003) Diagnosis of prostate cancer—the clinical use of prostate specific antigen. EAU Update Series 1:3–8CrossRef
2.
go back to reference Astraldi A (1937) Diagnosis of cancer of the prostate; biopsy by rectal route. Urol Cutan Rev 41:421–427 Astraldi A (1937) Diagnosis of cancer of the prostate; biopsy by rectal route. Urol Cutan Rev 41:421–427
3.
go back to reference Binsaleh S, Al-Assiri M, Aronson S et al (2004) Septic shock after transrectal ultrasound guided prostate biopsy. Is ciprofloxacin prophylaxis always protecting? Can J Urol 11(4):2352–2353PubMed Binsaleh S, Al-Assiri M, Aronson S et al (2004) Septic shock after transrectal ultrasound guided prostate biopsy. Is ciprofloxacin prophylaxis always protecting? Can J Urol 11(4):2352–2353PubMed
4.
go back to reference Borer A, Gilad J, Sikuler E et al (1999) Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. J Infect 38(2):128–129PubMedCrossRef Borer A, Gilad J, Sikuler E et al (1999) Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. J Infect 38(2):128–129PubMedCrossRef
5.
go back to reference Meisel F, Jacobi C, Kollamr R et al (2003) Acute meningitis after transrectal prostate biopsy. Urologe A 42(12):1611–1615PubMedCrossRef Meisel F, Jacobi C, Kollamr R et al (2003) Acute meningitis after transrectal prostate biopsy. Urologe A 42(12):1611–1615PubMedCrossRef
6.
go back to reference Raaijmakers R, Kirkels WJ, Roobol MJ et al (2002) Complication rates and risk factors of 5,802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60:826–830PubMedCrossRef Raaijmakers R, Kirkels WJ, Roobol MJ et al (2002) Complication rates and risk factors of 5,802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60:826–830PubMedCrossRef
7.
go back to reference Sieber PR, Rommel FM, Agusta VE et al (1997) Antibiotic prophylaxis in ultrasound guide transrectal prostate biopsy. J Urol 157:2197–2200CrossRef Sieber PR, Rommel FM, Agusta VE et al (1997) Antibiotic prophylaxis in ultrasound guide transrectal prostate biopsy. J Urol 157:2197–2200CrossRef
8.
go back to reference Carey JM, Korman HJ (2001) Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol 66:82–85 Carey JM, Korman HJ (2001) Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol 66:82–85
9.
go back to reference Jeon SS, Woo SH, Hyun JH et al (2003) Bisacodyl can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology 62(3):461–466PubMedCrossRef Jeon SS, Woo SH, Hyun JH et al (2003) Bisacodyl can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology 62(3):461–466PubMedCrossRef
10.
go back to reference Shandera KC, Thibault GP, Deshon GE Jr (1998) Efficacy of one dose fluoroquinolone before prostate biopsy. Urology 52:641–643PubMedCrossRef Shandera KC, Thibault GP, Deshon GE Jr (1998) Efficacy of one dose fluoroquinolone before prostate biopsy. Urology 52:641–643PubMedCrossRef
11.
go back to reference Griffith BC, Morey AF, Ali-Khan MM (2002) Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 168:1021–1023PubMedCrossRef Griffith BC, Morey AF, Ali-Khan MM (2002) Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 168:1021–1023PubMedCrossRef
12.
go back to reference Aus G, Ahlgren G, Bergdahl S et al (1996) Infection after transrectal core biopsies of the prostate-risk factors and antibiotic prophylaxis. Br J Urol 77:851–855PubMed Aus G, Ahlgren G, Bergdahl S et al (1996) Infection after transrectal core biopsies of the prostate-risk factors and antibiotic prophylaxis. Br J Urol 77:851–855PubMed
13.
go back to reference Cooner WH, Mosley BR, Rutherford CL Jr et al (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal exam and prostate specific antigen. J Urol 143:1146–1154PubMed Cooner WH, Mosley BR, Rutherford CL Jr et al (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal exam and prostate specific antigen. J Urol 143:1146–1154PubMed
14.
go back to reference Rodriguez LV, Terris MK (1998) Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 160:2115–2120PubMedCrossRef Rodriguez LV, Terris MK (1998) Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 160:2115–2120PubMedCrossRef
15.
go back to reference Desmond PM, Clark J, Thompson IM et al (1993) Morbidity with contemporary prostate biopsy. J Urol 150:1425–1426PubMed Desmond PM, Clark J, Thompson IM et al (1993) Morbidity with contemporary prostate biopsy. J Urol 150:1425–1426PubMed
16.
go back to reference Brewster SF, Macgowan AP, Gingell JC (1994) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam. Br J Urol 76:351–354CrossRef Brewster SF, Macgowan AP, Gingell JC (1994) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam. Br J Urol 76:351–354CrossRef
17.
go back to reference Vallancien G, Prapotnich D, Veillon B et al (1991) Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 146:1308–1312PubMed Vallancien G, Prapotnich D, Veillon B et al (1991) Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 146:1308–1312PubMed
18.
go back to reference Enlund AL, Varenhorst E (1997) Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. Br J Urol 79:777–780PubMed Enlund AL, Varenhorst E (1997) Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. Br J Urol 79:777–780PubMed
19.
go back to reference Isen K, Kupeli B, Sinik Z et al (1999) Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomised study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol 31:491–495PubMedCrossRef Isen K, Kupeli B, Sinik Z et al (1999) Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomised study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol 31:491–495PubMedCrossRef
20.
go back to reference Cormio L, Berardi B, Callea A et al (2002) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs. piperacillin/tazobactam. BJU Int 90:700–702PubMedCrossRef Cormio L, Berardi B, Callea A et al (2002) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs. piperacillin/tazobactam. BJU Int 90:700–702PubMedCrossRef
21.
go back to reference Shandera KC, Thibault GP, Deshon Jr GE (1998) Variability in patient preparation for prostate biopsy among American urologists. Urology 52:644–646PubMedCrossRef Shandera KC, Thibault GP, Deshon Jr GE (1998) Variability in patient preparation for prostate biopsy among American urologists. Urology 52:644–646PubMedCrossRef
22.
go back to reference Davis M, Sofer M, Kim SS et al (2002) The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol 167:566–570PubMedCrossRef Davis M, Sofer M, Kim SS et al (2002) The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol 167:566–570PubMedCrossRef
23.
go back to reference Taylor HM, Bingham JB (1997) The use of prophylactic antibiotics in ultrasound-guided transrectal prostate biopsy. Clin Radiol 52:787–790PubMedCrossRef Taylor HM, Bingham JB (1997) The use of prophylactic antibiotics in ultrasound-guided transrectal prostate biopsy. Clin Radiol 52:787–790PubMedCrossRef
24.
go back to reference Drusano GL, Preston SL, Van Guilder M et al (2000) A population pharmakokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrob Agents Chemother 44:2046–2051PubMedCrossRef Drusano GL, Preston SL, Van Guilder M et al (2000) A population pharmakokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrob Agents Chemother 44:2046–2051PubMedCrossRef
25.
go back to reference Kapoor DA, Klimberg IW, Malek GH et al (1998) Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 52:552–558PubMedCrossRef Kapoor DA, Klimberg IW, Malek GH et al (1998) Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 52:552–558PubMedCrossRef
26.
go back to reference Peyromaure M, Ravery V, Messas S (2002) Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients. J Urol 167:218–221PubMedCrossRef Peyromaure M, Ravery V, Messas S (2002) Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients. J Urol 167:218–221PubMedCrossRef
27.
go back to reference Aron M, Rajeev J, Gupta NP (2000) Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85:682–685PubMedCrossRef Aron M, Rajeev J, Gupta NP (2000) Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85:682–685PubMedCrossRef
28.
29.
go back to reference Hodge KK, McNeal JE, Terris MK (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74PubMed Hodge KK, McNeal JE, Terris MK (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74PubMed
30.
go back to reference de la Taille A, Antiphon P, Salomon L et al (2003) Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 61:1181–1186CrossRef de la Taille A, Antiphon P, Salomon L et al (2003) Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 61:1181–1186CrossRef
31.
go back to reference Brown RW, Warner JJ, Turner BI et al (1981) Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology 18:145–148PubMedCrossRef Brown RW, Warner JJ, Turner BI et al (1981) Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology 18:145–148PubMedCrossRef
32.
go back to reference Lindert KA, Kabalin JN Terris MK (2000) Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 164:76–80PubMedCrossRef Lindert KA, Kabalin JN Terris MK (2000) Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 164:76–80PubMedCrossRef
Metadata
Title
Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal prostate biopsy
Authors
Athanasios N. Argyropoulos
Konstantinos Doumas
Antonios Farmakis
Ioannis Liakatas
Ioannis Gkialas
Michael Lykourinas
Publication date
01-09-2007
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2007
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-006-9112-7

Other articles of this Issue 3/2007

International Urology and Nephrology 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.